CS
PRVL

Credit Suisse’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Credit Suisse’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-96,567
Closed -$2.23M – 3690
2020
Q4 		$2.23M Buy
+96,567
New +$2.23M ﹤0.01% 2060